D（6か月以上） Osaka Univ. D (more than 6 months) C57BL(N8)759F759 covid19_onset true F759 F759 B6.Cg-Il6st<tm1Thir>/ThirRbrc RBRC01532 In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. J. Exp Med., 196, 979-990 (2002). Immunity, 12, 95-105 (2000). Necessary documents for ordering:<ol><li>Order form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_4.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_b.docx">English</A>)</li><li>Category I MTA: MTA for distribution with RIKEN BRC (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_5.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_c.docx">English</A>)</li><li>Acceptance of responsibility for living modified organism (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_7.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_g.docx">English</A>)</li></ol><A HREF="https://www.med.osaka-u.ac.jp/pub/molonc/www/Eindex.html" target="_blank">Lab HP</A> Immunology and Inflammation Research 条件を付加する。<br>研究成果の公表にあたって寄託者の指定する文献を引用する。J. Exp Med., 196, 979-990 (2002). Immunity, 12, 95-105 (2000). 国立大学法人大阪大学 F759, C57BL(N8)759F759 human gp130遺伝子 cDNA, E. coli neo 遺伝子 Toshio HIRANO 平野　俊夫